Anti-S12A1/ SLC12A1/ BSC1 monoclonal antibody

Anti-S12A1/ SLC12A1/ BSC1 antibody for FACS & in-vivo assay

Target products collectionGo to SLC12A1/SLC12A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T93878-Ab-1/ GM-Tg-hg-T93878-Ab-2Anti-Human SLC12A1 monoclonal antibodyHuman
GM-Tg-rg-T93878-Ab-1/ GM-Tg-rg-T93878-Ab-2Anti-Rat SLC12A1 monoclonal antibodyRat
GM-Tg-mg-T93878-Ab-1/ GM-Tg-mg-T93878-Ab-2Anti-Mouse SLC12A1 monoclonal antibodyMouse
GM-Tg-cynog-T93878-Ab-1/ GM-Tg-cynog-T93878-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC12A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T93878-Ab-1/ GM-Tg-felg-T93878-Ab-2Anti-Feline SLC12A1 monoclonal antibodyFeline
GM-Tg-cang-T93878-Ab-1/ GM-Tg-cang-T93878-Ab-2Anti-Canine SLC12A1 monoclonal antibodyCanine
GM-Tg-bovg-T93878-Ab-1/ GM-Tg-bovg-T93878-Ab-2Anti-Bovine SLC12A1 monoclonal antibodyBovine
GM-Tg-equg-T93878-Ab-1/ GM-Tg-equg-T93878-Ab-2Anti-Equine SLC12A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T93878-Ab-1/ GM-Tg-hg-T93878-Ab-2; GM-Tg-rg-T93878-Ab-1/ GM-Tg-rg-T93878-Ab-2;
GM-Tg-mg-T93878-Ab-1/ GM-Tg-mg-T93878-Ab-2; GM-Tg-cynog-T93878-Ab-1/ GM-Tg-cynog-T93878-Ab-2;
GM-Tg-felg-T93878-Ab-1/ GM-Tg-felg-T93878-Ab-2; GM-Tg-cang-T93878-Ab-1/ GM-Tg-cang-T93878-Ab-2;
GM-Tg-bovg-T93878-Ab-1/ GM-Tg-bovg-T93878-Ab-2; GM-Tg-equg-T93878-Ab-1/ GM-Tg-equg-T93878-Ab-2
Products NameAnti-SLC12A1 monoclonal antibody
Formatmab
Target NameSLC12A1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC12A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species S12A1/ SLC12A1/ BSC1 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T93878
    Target NameSLC12A1
    Gene ID6557,20495,25065,714289,478292,101100216,407161
    Gene Symbol and SynonymsBSC,BSC-1,BSC1,CCC2,D630042G03Rik,mBSC1,NKCC2,SLC12A1,urehr3
    Uniprot AccessionQ13621,P55016
    Uniprot Entry NameS12A1_HUMAN,S12A1_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseHyperaldosteronism
    Gene EnsemblENSG00000074803
    Target ClassificationN/A

    The target: SLC12A1, gene name: SLC12A1, also named as BSC1, NKCC2. This gene encodes a kidney-specific sodium-potassium-chloride cotransporter that is expressed on the luminal membrane of renal epithelial cells of the thick ascending limb of Henle's loop and the macula densa. It plays a key role in concentrating urine and accounts for most of the NaCl resorption. It is sensitive to such diuretics as furosemide and bumetanide. Some Bartter-like syndromes result from defects in this gene. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their biological validity in humans has not been experimentally proven.[provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.